NURIX THERAPEUTICS INC. - COMMON STOCK

Nurix Therapeutics Announces IND clearance for DeTIL-0255, a drug-enhanced autologous T cell therapy for the potential treatment of a variety of solid tumors

12 ноя 2021 07:09:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Presents Beneficial Effects of CBL-B Inhibition on Human Tumor Infiltrating Lymphocytes at SITC Conference

12 ноя 2021 07:07:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics to Participate in Upcoming Investor Conferences

09 ноя 2021 16:01:01 Источник Nasdaq GlobeNewswire

Nurix Therapeutics to Present Initial Target Degradation Data from First Phase 1 Trial of NX-2127 in B Cell Malignancies at the 4th Annual Targeted Protein Degradation Summit

26 окт 2021 16:02:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics to Participate in the 4th Annual Targeted Protein Degradation Summit

21 окт 2021 07:00:01 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

14 окт 2021 16:02:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Expands its Board of Directors with the Addition of Two Industry Leaders

30 сен 2021 07:00:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

13 июл 2021 16:01:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Appointment of Stefani A. Wolff as Chief Operating Officer and Executive Vice President, Product Development

21 июн 2021 16:01:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Presentation of Preclinical Data from NX-5948 Program Demonstrating Significant Reduction of Inflammation in a Model of Autoimmune Disease

02 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Appoints Industry Leader Clay Siegall, Ph.D., to its Board of Directors

01 июн 2021 16:00:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Upcoming Presentation of NX-5948 Preclinical Data at the EULAR 2021 Virtual Congress

21 май 2021 07:00:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics to Participate in Upcoming Investor Conferences

11 май 2021 07:00:01 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

13 апр 2021 16:01:02 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

07 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers

16 мар 2021 09:31:21 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Presentation of NX-1607 Preclinical Data at AACR

10 мар 2021 17:12:18 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

09 мар 2021 16:01:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics to Participate and Present at Upcoming Investor Conferences

09 мар 2021 07:30:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

04 мар 2021 20:01:29 Источник Nasdaq GlobeNewswire